Member Info for TerrorWit

I have to address the staggering premise at play here.

We are being asked to believe that a handful of anonymous posters on an obscure internet forum possess greater technical and legal insight than the armies of professional advisors hired by LG, a $50 billion global corporation.

LG, with access to the world's best patent lawyers, materials scientists, and forensic analysts, conducted a deep investigation. Their expert, multi-million dollar assessment of the risk was clear: Settle with Nanoco for $5 million.

Yet, according to some here, LG's experts were fools. The real truth is found in a few Google searches and AI chats, performed by people with zero access to the actual evidence, products, or legal discovery.

This isn't skepticism. It's hubris. It's the belief that forum research can outsmart the combined due diligence of a multinational giant and its adversaries.

You can debate "colloidal vs. MCC" all day. It's irrelevant. The only opinion that mattered was LG's. They rendered their verdict with a cheque. Everything else is fan fiction.

Let's cut through the technical noise with simple logic.

The narrative has a fatal contradiction:

1. Assertion: Shoei's process is so clearly non-infringing that LG had no reason to pay Nanoco $5 million.

2. Action: Shoei is now spending heavily on a federal lawsuit because it is not certain it doesn't infringe and needs a court's permission to keep supplying LG.

Both cannot be true. If Shoei were so clearly in the right, there would be no lawsuit.

LG's settlement is the commercial verdict. Shoei's lawsuit is the scared reaction to it. The rest is commentary.

Way too much ego, not enough analysis and all based on performative expertise. This discussion has become about winning the forum, not understanding the situation.

——————

One simple fact overshadows every claim about who manufactures the most dots: Samsung is the only company that has successfully sold cadmium-free quantum dot displays to the mass consumer market at scale.

And for that, they paid Nanoco approximately $150 million.

That is the only market validation that matters. It's not about patents in a vacuum, or tons of unsold cadmium-based material in a warehouse, or unverifiable claims from private companies like Nanosys. It's about successful, monetisable integration into winning products.

We're getting lost in technical speculation none of us are truly qualified to judge. The patents are intensely complex.

We don't need to be experts. We only need to listen to the company and observe the outcomes.

For over a decade, Nanoco's straightforward, public claim has been: Nobody else has the relevant patents to make cadmium-free quantum dots at scale.

That claim is not marketing. It is the foundation of their entire business and litigation strategy. A listed company cannot maintain such a position frivolously.

That claim has now been tested and validated twice in the real world:

1. Against Samsung – Result: ~$150m settlement.

2. Against LG – Result: $5m settlement.

These are not opinions or research papers. These are financial settlements from global giants, each with access to the best legal and technical minds on the planet. They assessed the patents and chose to pay.

Shoei's action is not a disproof of this claim; it is the direct reaction to its validation. The commercial reality has shifted. The question is no longer about obscure chemical processes, but about how that validated claim is further monetized.

The technical debate is a distraction. The evidence of value is in the bank.

The price is noise in an illiquid stock. The signal is in the commercial reality.

Ask one question: After a $5m settlement, would LG happily keep buying dots from Shoei? Or are they already looking for a licensed supplier, ie Nanoco?

Maybe Shoei isn't just fighting a lawsuit; it's fighting to keep its biggest customer. That's why I think this will settle relatively quickly, and why Nanoco holds the leverage.

A quick note on the 19 December deadline.

This is a procedural date for Nanoco to answer Shoei's complaint. In complex IP litigation, the first move by competent counsel is almost always a request for an extension of time. So unless Nanoco had a ready rehearsed answer ready for the Shoei case then that's what we should expect.

This isn't a sign of weakness or dithering; it's standard practice to allow for a thorough analysis of the claims, the venue, and the formulation of the optimal response (which could include moving to dismiss or to transfer the case).

Expect a routine filing, not a dramatic ruling. The legal process is a marathon, not a sprint.

BFJ raises the critical technical question at the heart of this: the scope of Nanoco's IP around MCC versus other CFQD methods. This is indeed what the Virginia case will explore.

However, the market and the law don't operate on technical speculation alone; they operate on evidence and outcomes. The most significant piece of evidence we have is not a patent filing, but the LG settlement.

Let's connect the known facts:

1. Nanoco sued LG for infringement.

2. During discovery, the supply chain would have been examined.

3. LG settled for $5m in a no-fault, confidential agreement.

4. Shoei, identified as the supplier, has now filed for a declaratory judgment.

The logical inference from this sequence is powerful: The LG settlement likely revealed an infringement risk substantial enough for LG to pay to make it go away. Shoei's filing is a reactive move to that settled case, not a confident, pre-emptive strike from a position of strength.

If Shoei's non-MCC process were so clearly outside Nanoco's IP, why would its customer LG settle? Why would Shoei or Nanosys not have sought this clarity years ago, before shipping "tons" of material?

This suggests Nanoco's IP position is broader than the "MCC-only" argument implies, or that the line between MCC and non-MCC in commercial production is fuzzier than theorized.

The strategic reality is this: Shoei is now spending money to answer a question that its own customer already answered with a cheque. Nanoco, with its war chest from that same cheque, can afford to defend its position. This looks less like a Betamax moment and more like the next step in monetizing a portfolio that has already proven its worth against two industry giants.

The 19th will be procedural. The real guide is the pattern of outcomes: when challenged, Nanoco's IP results in settlements. That pattern remains unbroken.

Thin-skinned loser. Can't you tell? - You're talking about you.

The irony of being accused of being "behind" on bullish news by someone who spent years as the forum's chief bed wetteris truly remarkable.

It seems the strategy has shifted. Having been proven comprehensively wrong on the fundamental thesis—the value of the IP, the security of the cash runway, the significance of the JDAs—the only move left is to try and co-opt the positive narrative, while still lacing it with personal attacks to save face.

It's a transparent attempt to stay relevant in a conversation that has intellectually moved on. The facts are now so overwhelmingly positive that even the most entrenched skeptics are being forced to acknowledge them

The most significant news for Nanoco in months has just been published—by its main competitor, Nanosys.

The EU's final closure of the cadmium exemption is not just another news item; it's a structural, permanent change to the market that fundamentally advantages Nanoco.

1. A Competitor's Capitulation: Nanosys is publicly announcing the end of the road for their core high-cadmium technology.

2. Validation of Leadership: They state that "heavy metal free materials... lead the market with over 70 percent share." Nanoco is the leader in heavy metal-free QDs.

3. A Regulatory Moat: The EU market is now legally mandated toward the technology Nanoco pioneered and owns. This is a barrier that cannot be invented around easily.

This transforms the investment case. The value of Nanoco's IP portfolio is no longer speculative; it's underwritten by EU law. This strengthens their hand in every single discussion: the CDX process, the Shoei litigation, and future JDAs.

The landscape has permanently shifted, and Nanoco holds the high ground

Shoei has made the first move by filing in a venue of its choice. The critical next phase will be Nanoco's response. Their legal team will likely counter by either:

1. Arguing to dismiss or move the case, or;

2. Filing their own, stronger, infringement lawsuit against Shoei in a more favorable venue, like the Eastern District of Texas.

This isn't a sign of things going wrong; it's the standard, complex process of high-stakes IP litigation. The fact that Shoei felt the need to make this pre-emptive move is a testament to the perceived strength of Nanoco's portfolio.

The LG settlement cash means Nanoco is not a vulnerable target. They have the resources to engage in this fight properly and defend their assets, turning this legal challenge into another potential monetization event.

An even more likely scenario than Shoei being a bidder is that they are a disruptor.

As a small company, their worst-case scenario is a well-funded multinational acquiring Nanoco's IP to compete against them directly. This lawsuit could be a cheap (for now) tactic to spoil the CDX process, introduce uncertainty for other bidders, and, most importantly, buy themselves crucial time to get their own products to market before a new, powerful competitor emerges.

This isn't the action of a confident suitor; it's the move of a desperate competitor who sees the walls closing in.

The theory that Shoei is an active bidder using this lawsuit to manipulate the CDX process seems a significant leap, unsupported by the more logical commercial reality.

If Shoei were a genuine bidder, their rational and cost-effective path would be to increase their offer, not to initiate a costly legal battle. A lawsuit would:

· Antagonize the seller.

· Risk an adverse ruling that could permanently devalue the very asset they want to acquire.

· Be far more expensive and uncertain than simply paying a higher premium.

· and, if they lose, increase Nanoco's market value.

The simpler, and far more likely, explanation is that Shoei is a competitor that sees Nanoco's IP as a major threat following the LG settlement, and is seeking legal clarity to de-risk its own business plans.

The only valid concern is a potential short-term delay to the CDX process. However, if the board is confident in its IP—as the Samsung and LG outcomes suggest it should be—this action does not destroy value but rather publicly reaffirms it. It may even strengthen their hand by demonstrating to all bidders that the IP is a formidable market barrier.

If you find the logic and clarity of the analysis to be unfamiliar, that's your problem. The point stands, regardless of the tool used to articulate it.

Today's announcement is more than just validation of Nanoco's IP; it's a setup for a negotiation.

Shoei's declaratory judgement action is a classic legal and business tactic. By forcing the issue into court, they are not just seeking clarity—they are creating a powerful incentive for both parties to avoid a binary, high-risk trial and instead negotiate a settlement.

For Shoei, a loss could be catastrophic, blocking their market entry. For Nanoco, a guaranteed licensing fee from a direct competitor is superior to the cost and risk of litigation.

This move effectively puts a ticking clock on discussions for a potential license agreement. Shoei needs freedom to operate; Nanoco has the keys. This is how valuable IP gets monetized.

Far from a negative, this is the next logical step in the lifecycle of a dominant patent portfolio. It forces competitors to the table

A key data point in the settlement RNS is what it doesn't say: there is no mention of a license grant.

This is strategically significant.

If this were a simple "fire sale" to clean up the books, the logical step for LG would have been to demand a full and final release, including a license to use the IP going forward. The fact this didn't happen is telling.

It means the settlement cleanly resolves the past infringement but intentionally leaves the door open for the future. Nanoco has retained its right to pursue a separate, forward-looking commercial license with LG. This would be a new, potential revenue stream to be negotiated on its own terms, not bundled into a legal dispute as with Samsung.

Rather than a sign of weakness, the structure of this deal points to a board thinking strategically. They've secured a solid cash payment for the past without giving away the future value of their IP for free.

The LG settlement is a clear and material positive that strengthens the investment case on three fronts:

1. Immediate Cash Value: The gross $5m (£4m) settlement is pure, new cash the market had not priced in. With legal costs already met from the balance sheet, this translates to a direct +2p per share injection. This alone is a significant return for a ~9.5p stock.

2. Significant Derisking: The market expected a multi-year, costly legal battle. A swift resolution removes a major overhang, eliminates future legal fees, and provides certainty. This strategic derisking has a value beyond the raw cash and justifies a share price increase beyond the 2p base.

3. A Stronger CDX Proposition: For a potential acquirer, the story is now cleaner and more valuable.

· Enhanced IP Validation: A second multi-million dollar settlement proves the IP portfolio is a persistent, monetizable asset, not a one-off with Samsung.

· Extended Runway: The cash adds another year of operational funding, giving the board and any buyer more flexibility and time.

· No Legal Loose Ends: The business is a more straightforward, derisked acquisition target.

Kooba

You being a name-calling pedant tells us nothing about Nanoco but it tells the world everything about you.

Take out salaries and rent and what have you got?

....?

Key Takeaways

· Path to Production is Quantified: The Runcorn plant can scale to produce material for over 700 million sensors, with a cost of just $0.12-$0.25 per sensor, providing a clear, scalable blueprint for high-volume markets.

· Technology is Best-in-Class: New InAs photodetectors show leading performance metrics (Dark Current & Quantum Efficiency), validating claims of a sustainable technological edge.

· Financial Runway is Secure: With £14.0m cash and a controlled £0.5m monthly burn, the runway extends well into the future, fully funded through the current development phase.

· Revenue Visibility for FY26: A £7.6m orderbook provides significant revenue coverage for the coming year's operational costs, drastically reducing near-term risk.

· CDX Process is Active & Nearing Conclusion: The board confirmed the strategic review is "nearing completion" with continuing discussions, directly countering narratives of a failed or stalled process.

· Strategy is Focused & Validated: With two JDAs focused on high-volume consumer applications and a streamlined cost base, the company is executing a clear, credible plan for commercialization and value creation.